J u m p t o c o n t e n t
M a i n m e n u
M a i n m e n u
N a v i g a t i o n
● M a i n p a g e ● C o n t e n t s ● C u r r e n t e v e n t s ● R a n d o m a r t i c l e ● A b o u t W i k i p e d i a ● C o n t a c t u s ● D o n a t e
C o n t r i b u t e
● H e l p ● L e a r n t o e d i t ● C o m m u n i t y p o r t a l ● R e c e n t c h a n g e s ● U p l o a d f i l e
S e a r c h
Search
A p p e a r a n c e
● C r e a t e a c c o u n t ● L o g i n
P e r s o n a l t o o l s
● C r e a t e a c c o u n t ● L o g i n
P a g e s f o r l o g g e d o u t e d i t o r s l e a r n m o r e ● C o n t r i b u t i o n s ● T a l k
( T o p )
1 M e d i c a l u s e s
2 S o c i e t y a n d c u l t u r e
3 S e e a l s o
4 R e f e r e n c e s
T o g g l e t h e t a b l e o f c o n t e n t s
R i f a m p i c i n / i s o n i a z i d / p y r a z i n a m i d e
7 l a n g u a g e s
● ا ل ع ر ب ي ة ● E s p a ñ o l ● ف ا ر س ی ● ଓ ଡ ଼ ି ଆ ● С р п с к и / s r p s k i ● S r p s k o h r v a t s k i / с р п с к о х р в а т с к и ● T i ế n g V i ệ t
E d i t l i n k s
● A r t i c l e ● T a l k
E n g l i s h
● R e a d ● E d i t ● V i e w h i s t o r y
T o o l s
T o o l s
A c t i o n s
● R e a d ● E d i t ● V i e w h i s t o r y
G e n e r a l
● W h a t l i n k s h e r e ● R e l a t e d c h a n g e s ● U p l o a d f i l e ● S p e c i a l p a g e s ● P e r m a n e n t l i n k ● P a g e i n f o r m a t i o n ● C i t e t h i s p a g e ● G e t s h o r t e n e d U R L ● D o w n l o a d Q R c o d e ● W i k i d a t a i t e m
P r i n t / e x p o r t
● D o w n l o a d a s P D F ● P r i n t a b l e v e r s i o n
A p p e a r a n c e
F r o m W i k i p e d i a , t h e f r e e e n c y c l o p e d i a
3D structure Rifampicin/isoniazid/pyrazinamide
Rifampicin/isoniazid/pyrazinamide , also known as rifampin/isoniazid/pyrazinamide , and sold under the trade name Rifater , is a medication used to treat tuberculosis .[1] fixed dose combination of rifampicin , isoniazid , and pyrazinamide .[1] antituberculosis medication .[1] by mouth .[1]
Side effects are those of the underlying medications.[1] [2] liver problems .[3] [3] pregnancy is safe for the baby.[3]
Rifampicin/isoniazid/pyrazinamide was approved for medical use in the United States in 1994.[3] World Health Organization's List of Essential Medicines .[4]
Medical uses
[ edit ]
The hope of a fixed-dose combination pill is to increase the likelihood that people will take all of three medications.[5] [citation needed
Society and culture
[ edit ]
It is manufactured by Aventis .[citation needed
See also
[ edit ]
References
[ edit ]
^ a b c d "Rifater - FDA prescribing information, side effects and uses" . www.drugs.com . October 2016. Archived from the original on 21 December 2016. Retrieved 18 December 2016 .
^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019 . Geneva: World Health Organization. hdl :10665/325771
^ Brown MJ, Sharma P, Bennett PN (30 July 2012). Clinical Pharmacology ISBN 978-0-7020-5113-5
t
e
R e t r i e v e d f r o m " https://en.wikipedia.org/w/index.php?title=Rifampicin/isoniazid/pyrazinamide&oldid=1190628276 " C a t e g o r i e s : ● A n t i - t u b e r c u l o s i s d r u g s ● C o m b i n a t i o n a n t i b i o t i c s ● R i f a m y c i n a n t i b i o t i c s ● S a n o f i ● W o r l d H e a l t h O r g a n i z a t i o n e s s e n t i a l m e d i c i n e s ● A n t i i n f e c t i v e a g e n t s t u b s H i d d e n c a t e g o r i e s : ● A r t i c l e s w i t h s h o r t d e s c r i p t i o n ● S h o r t d e s c r i p t i o n i s d i f f e r e n t f r o m W i k i d a t a ● U s e d m y d a t e s f r o m S e p t e m b e r 2 0 1 9 ● D r u g s w i t h n o n - s t a n d a r d l e g a l s t a t u s ● C h e m i c a l s t h a t d o n o t h a v e a C h e m S p i d e r I D a s s i g n e d ● A r t i c l e s w i t h o u t E B I s o u r c e ● C h e m i c a l p a g e s w i t h o u t D r u g B a n k i d e n t i f i e r ● A r t i c l e s w i t h o u t I n C h I s o u r c e ● A r t i c l e s w i t h o u t U N I I s o u r c e ● D r u g s t h a t a r e a c o m b i n a t i o n o f c h e m i c a l s ● A l l a r t i c l e s w i t h u n s o u r c e d s t a t e m e n t s ● A r t i c l e s w i t h u n s o u r c e d s t a t e m e n t s f r o m A u g u s t 2 0 2 2 ● A r t i c l e s w i t h u n s o u r c e d s t a t e m e n t s f r o m S e p t e m b e r 2 0 1 9 ● W i k i p e d i a m e d i c i n e a r t i c l e s r e a d y t o t r a n s l a t e ● A l l s t u b a r t i c l e s
● T h i s p a g e w a s l a s t e d i t e d o n 1 9 D e c e m b e r 2 0 2 3 , a t 0 0 : 1 9 ( U T C ) . ● T e x t i s a v a i l a b l e u n d e r t h e C r e a t i v e C o m m o n s A t t r i b u t i o n - S h a r e A l i k e L i c e n s e 4 . 0 ;
a d d i t i o n a l t e r m s m a y a p p l y . B y u s i n g t h i s s i t e , y o u a g r e e t o t h e T e r m s o f U s e a n d P r i v a c y P o l i c y . W i k i p e d i a ® i s a r e g i s t e r e d t r a d e m a r k o f t h e W i k i m e d i a F o u n d a t i o n , I n c . , a n o n - p r o f i t o r g a n i z a t i o n . ● P r i v a c y p o l i c y ● A b o u t W i k i p e d i a ● D i s c l a i m e r s ● C o n t a c t W i k i p e d i a ● C o d e o f C o n d u c t ● D e v e l o p e r s ● S t a t i s t i c s ● C o o k i e s t a t e m e n t ● M o b i l e v i e w
